These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25098740)

  • 1. FRET imaging approaches for in vitro and in vivo characterization of synthetic lipid nanoparticles.
    Gravier J; Sancey L; Hirsjärvi S; Rustique E; Passirani C; Benoît JP; Coll JL; Texier I
    Mol Pharm; 2014 Sep; 11(9):3133-44. PubMed ID: 25098740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conventional versus stealth lipid nanoparticles: formulation and in vivo fate prediction through FRET monitoring.
    Lainé AL; Gravier J; Henry M; Sancey L; Béjaud J; Pancani E; Wiber M; Texier I; Coll JL; Benoit JP; Passirani C
    J Control Release; 2014 Aug; 188():1-8. PubMed ID: 24878182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inter-nanocarrier and nanocarrier-to-cell transfer assays demonstrate the risk of an immediate unloading of dye from labeled lipid nanocapsules.
    Simonsson C; Bastiat G; Pitorre M; Klymchenko AS; Béjaud J; Mély Y; Benoit JP
    Eur J Pharm Biopharm; 2016 Jan; 98():47-56. PubMed ID: 26522878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elimination study of intact lipid nanocapsules after intravenous rat administration.
    Lebreton V; Legeay S; Rapenne C; Saulnier P; Lagarce F
    Nanomedicine (Lond); 2024; 19(13):1123-1131. PubMed ID: 38690778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiscale Live Imaging Using Förster Resonance Energy Transfer (FRET) for Evaluating the Biological Behavior of Nanoparticles as Drug Carriers.
    Ishizawa K; Togami K; Tada H; Chono S
    J Pharm Sci; 2020 Dec; 109(12):3608-3616. PubMed ID: 32926888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of intact lipid nanocapsules using new quantitative FRET technique.
    Lebreton V; Kaeokhamloed N; Vasylaki A; Hilairet G; Mellinger A; Béjaud J; Saulnier P; Lagarce F; Gattacceca F; Legeay S; Roger E
    J Control Release; 2022 Nov; 351():681-691. PubMed ID: 36191672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferrociphenol lipid nanocapsule delivery by mesenchymal stromal cells in brain tumor therapy.
    Roger M; Clavreul A; Huynh NT; Passirani C; Schiller P; Vessières A; Montero-Menei C; Menei P
    Int J Pharm; 2012 Feb; 423(1):63-8. PubMed ID: 21554935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting.
    Morille M; Montier T; Legras P; Carmoy N; Brodin P; Pitard B; Benoît JP; Passirani C
    Biomaterials; 2010 Jan; 31(2):321-9. PubMed ID: 19800113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid nanocapsules for transdermal delivery of ropivacaine: in vitro and in vivo evaluation.
    Zhai Y; Yang X; Zhao L; Wang Z; Zhai G
    Int J Pharm; 2014 Aug; 471(1-2):103-11. PubMed ID: 24858383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative biodistribution in mice of cyanine dyes loaded in lipid nanoparticles.
    Mérian J; Boisgard R; Bayle PA; Bardet M; Tavitian B; Texier I
    Eur J Pharm Biopharm; 2015 Jun; 93():1-10. PubMed ID: 25805562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Copper-Mediated Disulfiram-Loaded pH-Triggered PEG-Shedding TAT Peptide-Modified Lipid Nanocapsules for Use in Tumor Therapy.
    Zhang L; Tian B; Li Y; Lei T; Meng J; Yang L; Zhang Y; Chen F; Zhang H; Xu H; Zhang Y; Tang X
    ACS Appl Mater Interfaces; 2015 Nov; 7(45):25147-61. PubMed ID: 26501354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo imaging of DNA lipid nanocapsules after systemic administration in a melanoma mouse model.
    David S; Carmoy N; Resnier P; Denis C; Misery L; Pitard B; Benoit JP; Passirani C; Montier T
    Int J Pharm; 2012 Feb; 423(1):108-15. PubMed ID: 21726617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of size, surface coating and fine chemical composition on the in vitro reactivity and in vivo biodistribution of lipid nanocapsules versus lipid nanoemulsions in cancer models.
    Hirsjärvi S; Dufort S; Gravier J; Texier I; Yan Q; Bibette J; Sancey L; Josserand V; Passirani C; Benoit JP; Coll JL
    Nanomedicine; 2013 Apr; 9(3):375-87. PubMed ID: 22960195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Administration-dependent efficacy of ferrociphenol lipid nanocapsules for the treatment of intracranial 9L rat gliosarcoma.
    Huynh NT; Passirani C; Allard-Vannier E; Lemaire L; Roux J; Garcion E; Vessieres A; Benoit JP
    Int J Pharm; 2012 Feb; 423(1):55-62. PubMed ID: 21536115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of dye and superparamagnetic iron oxide nanoparticle loaded lipid nanocapsules with dual detectability in vitro and in vivo.
    Bohley MS; Birch E; Baumann FJ; Dillinger AE; Tamm ER; Goepferich AM
    Int J Pharm; 2020 Jul; 585():119433. PubMed ID: 32447023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid nanocapsules maintain full integrity after crossing a human intestinal epithelium model.
    Roger E; Gimel JC; Bensley C; Klymchenko AS; Benoit JP
    J Control Release; 2017 May; 253():11-18. PubMed ID: 28274740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial action of lipid nanocapsules containing fatty acids or monoglycerides as co-surfactants.
    Umerska A; Cassisa V; Matougui N; Joly-Guillou ML; Eveillard M; Saulnier P
    Eur J Pharm Biopharm; 2016 Nov; 108():100-110. PubMed ID: 27597268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-sensing porphysomes for fluorescence-guided photothermal therapy.
    Ng KK; Takada M; Jin CC; Zheng G
    Bioconjug Chem; 2015 Feb; 26(2):345-51. PubMed ID: 25563975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. π-Conjugate Fluorophore-Tagged and Enzyme-Responsive l-Amino Acid Polymer Nanocarrier and Their Color-Tunable Intracellular FRET Probe in Cancer Cells.
    Saxena S; Jayakannan M
    Biomacromolecules; 2017 Aug; 18(8):2594-2609. PubMed ID: 28699735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel lipoprotein-mimic nanocarrier composed of the modified protein and lipid for tumor cell targeting delivery.
    Xu Y; Jin X; Ping Q; Cheng J; Sun M; Cao F; You W; Yuan D
    J Control Release; 2010 Sep; 146(3):299-308. PubMed ID: 20580913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.